1. Home
  2. AIMD vs ZDAI Comparison

AIMD vs ZDAI Comparison

Compare AIMD & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • ZDAI
  • Stock Information
  • Founded
  • AIMD 1984
  • ZDAI 2022
  • Country
  • AIMD United States
  • ZDAI Hong Kong
  • Employees
  • AIMD N/A
  • ZDAI N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • ZDAI General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • AIMD Health Care
  • ZDAI Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • ZDAI Nasdaq
  • Market Cap
  • AIMD 11.9M
  • ZDAI 13.5M
  • IPO Year
  • AIMD N/A
  • ZDAI 2024
  • Fundamental
  • Price
  • AIMD $3.63
  • ZDAI $0.47
  • Analyst Decision
  • AIMD
  • ZDAI
  • Analyst Count
  • AIMD 0
  • ZDAI 0
  • Target Price
  • AIMD N/A
  • ZDAI N/A
  • AVG Volume (30 Days)
  • AIMD 235.1K
  • ZDAI 825.1K
  • Earning Date
  • AIMD 08-13-2025
  • ZDAI 09-16-2025
  • Dividend Yield
  • AIMD N/A
  • ZDAI N/A
  • EPS Growth
  • AIMD N/A
  • ZDAI N/A
  • EPS
  • AIMD N/A
  • ZDAI N/A
  • Revenue
  • AIMD $110,870.00
  • ZDAI $19,275,673.00
  • Revenue This Year
  • AIMD N/A
  • ZDAI N/A
  • Revenue Next Year
  • AIMD N/A
  • ZDAI N/A
  • P/E Ratio
  • AIMD N/A
  • ZDAI N/A
  • Revenue Growth
  • AIMD 70.25
  • ZDAI 43.16
  • 52 Week Low
  • AIMD $2.00
  • ZDAI $0.37
  • 52 Week High
  • AIMD $5.00
  • ZDAI $107.36
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 54.86
  • ZDAI 38.27
  • Support Level
  • AIMD $3.56
  • ZDAI $0.46
  • Resistance Level
  • AIMD $4.19
  • ZDAI $0.51
  • Average True Range (ATR)
  • AIMD 0.27
  • ZDAI 0.06
  • MACD
  • AIMD -0.01
  • ZDAI 0.00
  • Stochastic Oscillator
  • AIMD 38.46
  • ZDAI 8.32

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About ZDAI Primega Group Holdings Limited Ordinary Shares

Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: